Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
2-year Postdoctoral Research Fellow position with focus on Cryptography at Computer Science Aarhu...
of Academic Staff at Danish Universities under the Danish Ministry of Science, Technology and Innovation . The application must be in English and include a curriculum vitae, degree certificate, a complete list
-
shape the future we envision. Summary Postdoc position is available in the laboratory of Dr. Dorina Avram in the Department of Immunology and Immuno-Oncology Program at the Moffitt Cancer Center to study
-
the dissertation defense passed. Demonstrated ability to conduct independent scientific research. Strong proficiency in English communication, reading, and writing. Excellent academic ethics and integrity, effective
-
in particular T cell biology is highly desirable Highly motivated with a strong interest in molecular immunology Excellent written and verbal communication skills in English, along with a collaborative
-
English. Demonstrated ability to work independently, set research objectives, and meet deadlines. Willingness to travel for collaboration and dissemination (Europe and beyond). Desirable Criteria Industrial
-
. Strong written and verbal skills in English are essential. PhDs from Cell Biology, Bioengineering, Biophysics, Biochemistry, Physiology, Immunology, Pharmaceutical Sciences, Pathology and Molecular Biology
-
. Special requirements for the position: FELASA certification (or Norwegian approved international equivalents) for work with laboratory animals. The applicant’s personal suitability for the position is a
-
to formulate and lead a research programme that will deliver innovative, world-class science in molecular host-microbes interactions or a related field and good knowledge of JIC/NRP research fields, underpinning
-
The University of Toronto is pleased to announce the third call for applications for theEric and Wendy Schmidt AI in Science Postdoctoral Fellowship , a program of Schmidt Sciences, which brings
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic